Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097852 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sydney R Grant und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA. Hauptthemen laut MEDLINE: Carcinogens, Urinary Bladder Neoplasms. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Roswell Park Alliance Foundation, National Cancer Institute (NCI), the Center for Computational Research at the University at Buffalo.
Abstract (Originalsprache)
More than 80,000 new cases of bladder cancer are estimated to be diagnosed in 2023. However, the 5-year survival rate for bladder cancer has not changed in decades, highlighting the need for prevention. Numerous cancer-causing mutations are present in the urothelium long before signs of cancer arise. Mutation hotspots in cancer-driving genes were identified in non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) tumor samples. Mutation burden within the hotspot regions was measured in normal urothelium with a low and high risk of cancer. A significant correlation was found between the mutation burden in normal urothelium and bladder cancer tissue within the hotspot regions. A combination of measured hotspot burden and personal risk factors was used to fit machine learning classification models. The efficacy of each model to differentiate between adjacent benign urothelium from bladder cancer patients and normal urothelium from healthy donors was measured. A random forest model using a combination of personal risk factors and mutations within MIBC hotspots yielded the highest AUC of 0.9286 for the prediction of high- vs. low-risk normal urothelium. Currently, there are no effective biomarkers to assess subclinical field disease and early carcinogenic progression in the bladder. Our findings demonstrate novel differences in mutation hotspots in NMIBC and MIBC and provide the first evidence for mutation hotspots to aid in the assessment of cancer risk in the normal urothelium. Early risk assessment and identification of patients at high risk of bladder cancer before the clinical presentation of the disease can pave the way for targeted personalized preventative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Cancer Prevention & Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
ORCID-Profile: Sydney R Grant, Gyorgy Paragh, Wendy J Huss
Förderung
- NCI NIH HHS
- Roswell Park Alliance Foundation, National Cancer Institute (NCI)
- the Center for Computational Research at the University at Buffalo
Zitieren
APA
Grant, S. R., Tang, L., Wei, L., Foster, B. A., Paragh, G., & Huss, W. J. (2023). Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097852
Vancouver
Grant SR, Tang L, Wei L, Foster BA, Paragh G, Huss WJ. Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097852
BibTeX
@article{Grant2023,
author = {Grant, Sydney R and Tang, Li and Wei, Lei and Foster, Barbara A and Paragh, Gyorgy and Huss, Wendy J},
title = {Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097852}
}
EUVIMED